摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-hydroxy-3-methoxyphenyl)quinazolin-4(3H)-one

中文名称
——
中文别名
——
英文名称
2-(4-hydroxy-3-methoxyphenyl)quinazolin-4(3H)-one
英文别名
2-(4-Hydroxy-3-methoxyphenyl)quinazolin-4 (3h)-one;2-(4-hydroxy-3-methoxyphenyl)-3H-quinazolin-4-one
2-(4-hydroxy-3-methoxyphenyl)quinazolin-4(3H)-one化学式
CAS
——
化学式
C15H12N2O3
mdl
——
分子量
268.272
InChiKey
OIUTUDZPVAEFTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    70.9
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Discovery of Allosteric Modulators of Factor XIa by Targeting Hydrophobic Domains Adjacent to Its Heparin-Binding Site
    摘要:
    To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the V-max of substrate hydrolysis without influencing the K-M. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.
    DOI:
    10.1021/jm301757v
  • 作为产物:
    描述:
    靛红酸酐香草醛 在 copper(II) oxide 、 氯化铵 作用下, 以 乙醇 为溶剂, 以85%的产率得到2-(4-hydroxy-3-methoxyphenyl)quinazolin-4(3H)-one
    参考文献:
    名称:
    CuO纳米粒子在乙醇水溶液超声辐照下催化简单有效地合成2,3-二氢喹唑啉-4(1 H)-酮和喹唑啉-4(3 H)-酮
    摘要:
    一种由CuO纳米颗粒催化的一锅法,经设计可从容易获得的等角酸酐,醛和胺或铵制备各种喹唑啉酮。对于胺底物,反应得到在乙醇水溶液中由超声辐射促进的2,3-二氢喹唑啉-4(1 H)-one。然而,铵底物经历分子内电子转移和重排产生喹唑啉-4(3 H)一。该催化剂可循环使用四次而不会损失任何实质活性。其他显着特征还包括广泛的官能团耐受性(合成了46种喹唑啉酮,首先报道了其中的9种),并在温和条件下提供了中等至优异的收率。
    DOI:
    10.1016/j.tet.2014.05.059
点击查看最新优质反应信息

文献信息

  • Quinazoline derivatives as selective CYP1B1 inhibitors
    作者:Mohd Usman Mohd Siddique、Glen J.P. McCann、Vinay R. Sonawane、Neill Horley、Linda Gatchie、Prashant Joshi、Sandip B. Bharate、Venkatesan Jayaprakash、Barij N. Sinha、Bhabatosh Chaudhuri
    DOI:10.1016/j.ejmech.2017.02.032
    日期:2017.4
    potent and specific CYP1B1 inhibitors can lead to a novel treatment of cancer. Flavonoids have a compact rigid skeleton which fit precisely within the binding cavity of CYP1B1. Systematic isosteric replacement of flavonoid 'O' atom with 'N' atom led to the prediction that a 'quinazoline' scaffold could be the basis for designing potential CYP1B1 inhibitors. A total of 20 quinazoline analogs were synthesized
    CYP1B1与乳腺癌,卵巢癌,肾癌,皮肤癌和肺癌的发生有关。有人提出,确定有效的和特定的CYP1B1抑制剂可以导致癌症的新治疗。类黄酮具有紧密的刚性骨架,可以精确地装配在CYP1B1的结合腔内。用“ N”原子对类黄酮“ O”原子进行系统等位取代,导致预测“喹唑啉”骨架可能是设计潜在CYP1B1抑制剂的基础。合成了总共20种喹唑啉类似物,并在Sacchrosomes™中筛选了CYP1B1和CYP1A1抑制作用。六种具有抑制CYP1B1能力的化合物的IC50测定结果表明,喹唑啉5c和5h是CYP1B1抑制作用的最佳候选者,IC50值在nM范围内。属于CYP1,CYP2和CYP3酶家族的同源CYP的进一步选择性研究表明,这些化合物可能没有关键的药物相互作用。进行分子建模研究以合理化所观察到的酶促抑制作用。对具有CYP1A1和CYP1B1酶的活酵母和人细胞的进一步生物学研究表明,最有效的化合物具有
  • [EN] ALLOSTERIC MODULATORS OF FACTOR XIa AS ANTICOAGULANT AGENTS<br/>[FR] MODULATEURS ALLOSTÉRIQUES DE FACTEUR XIA EN TANT QU'AGENTS ANTICOAGULANTS
    申请人:UNIV VIRGINIA COMMONWEALTH
    公开号:WO2014075045A1
    公开(公告)日:2014-05-15
    Compounds which allosterically modulate and/or inhibit factor XIa activity are provided, as are methods of their use. These compounds include i) sulfated gallolyl glucosides, ii) sulfated quinazolinones, and iii) sulfated inositol analogs. The compounds used as anticoagulant agents.
    提供了能够以别构调节和/或抑制XIa因子活性的化合物,以及它们的使用方法。这些化合物包括i) 硫酸酯化没食子醇葡萄糖苷,ii) 硫酸酯喹唑啉酮,和iii) 硫酸酯化肌醇类似物。这些化合物被用作抗凝剂。
  • Benign and Efficient Synthesis of 2-Substituted 4(3<i>H</i>)-Quinazolinones Mediated by Iron(III) Chloride Hexahydrate in Refluxing Water
    作者:Guan-Wu Wang、Chun-Bao Miao、Hui Kang
    DOI:10.1246/bcsj.79.1426
    日期:2006.9
    Condensation of aldehydes with anthranilamide in refluxing water using iron(III) chloride hexahydrate as an oxidiant afforded 2-substituted 4(3H)-quinazolinones in good yields (77-93%). This method provides several advantages such as being environmentally friendly, having a simple work-up procedure, and affording high yields.
    醛与邻基苯甲酰胺在回流中使用六水合氯化铁 (III) 作为氧化剂缩合,以良好的产率 (77-93%) 得到 2-取代的 4(3H)-喹唑啉酮。该方法具有多种优点,例如环境友好、后处理程序简单、收率高。
  • A Cu (NO3)2.3H2O catalysed facile synthesis of substituted 4(3H)-quinazolinones and benzimidazoles
    作者:G A N K DURGAREDDY、R RAVIKUMAR、S RAVI、SRINIVAS R ADAPA
    DOI:10.1007/s12039-012-0343-0
    日期:2013.1
    One pot synthesis of alkyl, aryl, heteroaryl mono(2)substituted 4(3H)-quinazolinones and 2-aryl or heteroaryl, 1-arylmethyl or heteroarylmethyl -1H-benzimidazoles using a water soluble Cu (NO3)2.3H2O catalyst at room/ambient temperature in excellent yield. One pot synthesis of alkyl, aryl, heteroaryl mono(2)substituted 4(3H)-quinazolinones and 2-aryl or heteroaryl, 1-arylmethyl or heteroarylmethyl-1H-benzimidazoles
    使用溶性Cu(NO 3)2 .3H 2 O一锅合成烷基,芳基,杂芳基单(2)取代的4(3H)-喹唑啉酮和2-芳基或杂芳基,1-芳基甲基或杂芳基甲基-1H-苯并咪唑在室温/环境温度下以优异的收率得到催化剂。 使用溶性Cu(NO 3)2 .3H 2 O一锅合成烷基,芳基,杂芳基单(2)取代的4(3H)-喹唑啉酮和2-芳基或杂芳基,1-芳基甲基或杂芳基甲基-1H-苯并咪唑据报道,该催化剂在室温/环境温度下具有优异的产率。
  • Synthesis and Evaluation of Antioxidant Properties of 2-Substituted Quinazolin-4(3H)-ones
    作者:Janez Mravljak、Lara Slavec、Martina Hrast、Matej Sova
    DOI:10.3390/molecules26216585
    日期:——
    Quinazolinones represent an important scaffold in medicinal chemistry with diverse biological activities. Here, two series of 2-substituted quinazolin-4(3H)-ones were synthesized and evaluated for their antioxidant properties using three different methods, namely DPPH, ABTS and TEACCUPRAC, to obtain key information about the structure–antioxidant activity relationships of a diverse set of substituents
    喹唑啉酮是药物化学中的重要支架,具有多种生物活性。在这里,合成了两个系列的2-取代喹唑啉-4(3 H )-酮,并使用三种不同的方法(即DPPHABTSTEAC CUPRAC )评估了它们的抗氧化性能,以获得有关结构与抗氧化活性关系的关键信息。主要喹唑啉酮支架的位置 2 上有一组不同的取代基。关于抗氧化活性,ABTSTEAC CUPRAC测定比 DPPH 测定更灵敏,结果更可靠。为了获得2-苯基喹唑啉-4( 3H )-酮的抗氧化活性,除了甲氧基取代基或苯环上邻位或对位的第二个羟基之外,还需要存在至少一个羟基。第二系列(化合物25a和25b )中存在喹唑啉酮环和取代基之间的额外乙烯连接基,导致抗氧化活性增加。此外,除了抗氧化活性外,苯环邻位上有两个羟基的衍生物还表现出属螯合性能。我们的研究成功地使用了三种不同的抗氧化活性评估方法,将 2-(2,3-二羟基苯基)喹唑啉-4(3 H
查看更多